AbbVie Inc. (ABBV)
209.73
4.44 (2.16%)
At close: Mar 31, 2025, 2:23 PM
209.07
-0.32%
Pre-market: Apr 01, 2025, 04:16 AM EDT
Duodopa Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 111M | -4M | -3.48% |
Mar 31, 2024 | 115M | n/a | n/a |
Dec 31, 2023 | 115M | -3M | -2.54% |
Sep 30, 2023 | 118M | 1M | +0.85% |
Jun 30, 2023 | 117M | -1M | -0.85% |
Mar 31, 2023 | 118M | 57M | +93.44% |
Dec 31, 2022 | 61M | -26M | -29.89% |
Sep 30, 2022 | 87M | -63M | -42.00% |
Jun 30, 2022 | 150M | -27M | -15.25% |
Mar 31, 2022 | 177M | -6M | -3.28% |
Dec 31, 2021 | 183M | 12M | +7.02% |
Sep 30, 2021 | 171M | n/a | n/a |
Jun 30, 2021 | 171M | 11M | +6.88% |
Mar 31, 2021 | 160M | -67M | -29.52% |
Dec 31, 2020 | 227M | 20M | +9.66% |
Sep 30, 2020 | 207M | 102M | +97.14% |
Jun 30, 2020 | 105M | n/a | n/a |
Mar 31, 2020 | n/a | n/a | n/a |
Dec 31, 2019 | n/a | n/a | n/a |
Sep 30, 2019 | n/a | n/a | n/a |
Jun 30, 2019 | n/a | n/a | n/a |
Mar 31, 2019 | n/a | n/a | n/a |
Dec 31, 2018 | n/a | n/a | n/a |
Sep 30, 2018 | n/a | n/a | n/a |
Jun 30, 2018 | n/a | n/a | n/a |
Mar 31, 2018 | n/a | n/a | n/a |
Dec 31, 2017 | n/a | n/a | n/a |
Sep 30, 2017 | n/a | n/a | n/a |
Jun 30, 2017 | n/a | n/a | n/a |
Mar 31, 2017 | n/a | n/a | n/a |
Dec 31, 2016 | n/a | n/a | n/a |
Sep 30, 2016 | n/a | n/a | n/a |
Jun 30, 2016 | n/a | n/a | n/a |
Mar 31, 2016 | n/a | n/a | n/a |
Dec 31, 2015 | n/a | n/a | n/a |
Sep 30, 2015 | n/a | n/a | n/a |
Jun 30, 2015 | n/a | n/a | n/a |
Mar 31, 2015 | n/a | n/a | n/a |
Dec 31, 2014 | n/a | n/a | n/a |
Sep 30, 2014 | n/a | n/a | n/a |
Jun 30, 2014 | n/a | n/a | n/a |
Mar 31, 2014 | n/a | n/a | n/a |
Dec 31, 2013 | n/a | n/a | n/a |
Sep 30, 2013 | n/a | n/a | n/a |
Jun 30, 2013 | n/a | n/a | n/a |
Mar 31, 2013 | n/a | n/a | n/a |